Cefiderocol in clinical practice: From randomised trials to real-world evidence in the management of multidrug-resistant Gram-negative bacterial infections

Journal of Infection · Published 2026-07-21 · DOI 10.1016/j.jinf.2026.106821

Free full text

Authors (3)

Francesca Di Bartolomeo, Matteo Augello, Giulia Marchetti

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Bartolomeo, F., Augello, M., Marchetti, G. (2026). Cefiderocol in clinical practice: From randomised trials to real-world evidence in the management of multidrug-resistant Gram-negative bacterial infections. Journal of Infection. https://doi.org/10.1016/j.jinf.2026.106821

Related articles

• A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment · Journal of Infection · 2026 · Same journal
• Global surveillance reveals progressive erosion of benzylpenicillin susceptibility in Streptococcus suis · Journal of Infection · 2026 · Same journal
• Home-based rapid testing and early antiviral treatment as a potential strategy to blunt pediatric influenza peak · Journal of Infection · 2026 · Same journal
• Remdesivir triphosphate as a potential repurposed drug against the emerging Bundibugyo Ebolavirus 2026 · Journal of Infection · 2026 · Same journal
• Metagenomic sequencing as a diagnostic tool for urine culture negative febrile urinary tract infection · Journal of Infection · 2026 · Same journal
• Global disability-adjusted life years burden of lower respiratory infections caused by Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae, 1990–2021: A systematic analysis of the global burden of disease study 2021 · Journal of Infection · 2026 · Same journal
• Long-term immunogenicity and safety of RZV primary vaccination and revaccination in kidney transplant recipients · Journal of Infection · 2026 · Same journal
• Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England · Journal of Infection · 2026 · Same journal
• Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025 · Journal of Infection · 2026 · Same journal
• Within-host evolution of tandemly duplicated blaKPC-14 conferring cross-resistance to ceftazidime-avibactam, cefiderocol and aztreonam-avibactam in hypervirulent ST11 Klebsiella pneumoniae · Journal of Infection · 2026 · Same journal